ArticleMolecular cancer therapeutics2022

Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival.

Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.